# Telemedicine in Atrial Fibrillation: Randomized Clinical Trial in Primary Care (AtrialConnect)

Study · id `cardio:ct-nct05893199` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05893199](<https://clinicaltrials.gov/study/NCT05893199>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05893199

Browse, organ or system: Heart  
Browse, condition area: Stroke; Heart rhythm problems  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 180 participants.

## Technical summary

Registry record NCT05893199. Randomized; no masking; primary purpose supportive care. Start 2023-09-01 (anticipated); primary completion 2024-12-31 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose supportive care
- Phase: Not applicable
- Enrolled: 180 participants (planned count; ClinicalTrials.gov record NCT05893199, source copy `cardio:ctgov-nct05893199-2023-06-07`, retrieved 2026-10-26)
- Planned start: 2023-09-01 (anticipated) (ClinicalTrials.gov record NCT05893199, source copy `cardio:ctgov-nct05893199-2023-06-07`, retrieved 2026-10-26)
- Primary completion: 2024-12-31 (anticipated) (ClinicalTrials.gov record NCT05893199, source copy `cardio:ctgov-nct05893199-2023-06-07`, retrieved 2026-10-26)
- Completion: 2025-06-30 (anticipated) (ClinicalTrials.gov record NCT05893199, source copy `cardio:ctgov-nct05893199-2023-06-07`, retrieved 2026-10-26)
- Countries: Not reported
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05893199-2023-06-07`, retrieved 2026-10-26)

## The registry's words

- Brief title: Telemedicine in Atrial Fibrillation: Randomized Clinical Trial in Primary Care (AtrialConnect)
- Condition: Atrial Fibrillation
- Intervention (Device): Clinical monitoring using the Ti.Care app (https://ti.care/es)
- Intervention (Other): Usual care
- Lead sponsor: Universidad Miguel Hernandez de Elche
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)
- Registry lists this organization as the lead sponsor: Universidad Miguel Hernandez de Elche (`cardio:org-universidad-miguel-hernandez-de-elche`)

## Provenance

Content hash: 16360dc1a59c4ee183aca41398522b155b333630f1fc4b83651612e76dce176b
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
